ReviewJournal of preventive medicine and public health = Yebang Uihakhoe chi2014
Cancer control programs in East Asia: evidence from the international literature.
Review in Journal of preventive medicine and public health = Yebang Uihakhoe chi, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Impact of interventions on the quality of life of cancer patients: a systematic review and meta-analysis of longitudinal research.Health and quality of life outcomes · 2023Pooled it
- Global patterns and burden of soft tissue and extraosseous sarcomas: trends from 1990 to 2021.BMC cancer · 2025Article
- Cancer functional states-based molecular subtypes of gastric cancer.Journal of translational medicine · 2023Article
- Diagnostic work-up and systemic treatment for advanced non-squamous non-small-cell lung cancer in four Southeast Asian countries.ESMO open · 2022Article
- Non-communicable disease policy implementation in Libya: A mixed methods assessment.PLOS global public health · 2022Article
- An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries.Globalization and health · 2021Article
- Identification of gastric cancer subtypes based on pathway clustering.NPJ precision oncology · 2021Article
- Molecular Subtypes of Breast Cancers from Myanmar Women: A Study of 91 Cases at Two Pathology CentersAsian Pacific journal of cancer prevention : APJCP · 2017Article
- Low prevalence of human mammary tumor virus (HMTV) in breast cancer patients from Myanmar.Infectious agents and cancer · 2017Article
- State of the Art of Stimuli-Responsive Liposomes for Cancer Therapy.Iranian journal of pharmaceutical research : IJPR · 2017Review
- Features of Malignancy Prevalence among Children in the Aral Sea RegionAsian Pacific journal of cancer prevention : APJCP · 2016Article
- Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2015Review
- Two hypotheses of dense breasts and viral infection for explaining incidence of breast cancer by age group in Korean women.Epidemiology and health · 2014Article
- Cancers in Vietnam-Burden and Control Efforts: A Narrative Scoping Review.Cancer control : journal of the Moffitt Cancer CenterArticle
- Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study.Scientia pharmaceuticaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer is a major cause of mortality and morbidity throughout the world, including the countries of North-East and South-East Asia. Assessment of burden through cancer registration, determination of risk and protective factors, early detection and screening, clinical practice, interventions for example in vaccination, tobacco cessation efforts and palliative care all should be included in comprehensive cancer control programs. The degree to which this is possible naturally depends on the resources available at local, national and international levels. The present review concerns elements of cancer control programs established in China, Taiwan, Korea, and Japan in North-East Asia, Viet Nam, Thailand, Malaysia, and Indonesia as representative larger countries of South-East Asia for comparison, using the published literature as a guide. While major advances have been made, there are still areas which need more attention, especially in South-East Asia, and international cooperation is essential if standard guidelines are to be generated to allow effective cancer control efforts throughout the Far East. Cancer is a major cause of mortality and morbidity throughout the world, including the countries of North-East and South-East Asia. Assessment of burden through cancer registration, determination of risk and protective factors, early detection and screening, clinical practice, interventions for example in vaccination, tobacco cessation efforts and palliative care all should be included in comprehensive cancer control programs. The degree to which this is possible naturally depends on the resources available at local, national and international levels. The present review concerns elements of cancer control programs established in China, Taiwan, Korea, and Japan in North-East Asia, Viet Nam, Thailand, Malaysia, and Indonesia as representative larger countries of South-East Asia for comparison, using the published literature as a guide. While major advances have been made, there are still areas which need more attention, especially in South-East Asia, and international cooperation is essential if standard guidelines are to be generated to allow effective cancer control efforts throughout the Far East.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.